AN2 Therapeutics, Inc.·4

Dec 23, 6:42 PM ET

Martin Patricia A. 4

4 · AN2 Therapeutics, Inc. · Filed Dec 23, 2024

Insider Transaction Report

Form 4
Period: 2024-12-19
Transactions
  • Award

    Common Stock

    2024-12-19+3,1663,166 total
Footnotes (1)
  • [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4